Abstract
Fusariosis, an emerging opportunistic mycosis caused by Fusarium species, carries a high mortality rate in immunocompromised patients. The dismal prognosis of patients with fusariosis is aggravated by the limited therapeutic options. Here we give an overview of the epidemiology, pathogenesis, clinical manifestations, antifungal susceptibility and management of fusariosis.
Original language | English (US) |
---|---|
Pages (from-to) | 28-35 |
Number of pages | 8 |
Journal | Journal of Chemotherapy |
Volume | 15 |
Issue number | SUPPL. 2 |
DOIs | |
State | Published - Nov 2003 |
Keywords
- Cancer
- Fusariosis
- Immunocompromised patients
- Invasive fungal infection
ASJC Scopus subject areas
- Oncology
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases